Reply to "Insights on Risk Score Development: Considerations for Early-Stage Hepatocellular Carcinoma Models"

Clin Mol Hepatol. 2024 Nov 11. doi: 10.3350/cmh.2024.0999. Online ahead of print.
No abstract available